BUPRENORFINA NEL DOLORE DA CANCRO: CONFRONTO INCROCIATO CON LA PENTAZOCINA

Translated title of the contribution: Buprenorphine in the treatment of cancer pain: Comparison with pentazocine

F. De Conno, C. Ripamonti, M. Tamburini, V. Ventafridda

Research output: Contribution to journalArticlepeer-review

Abstract

In a randomized cross-study analgesic activity and side effects of two narcotics, buprenorphine and pentazocine, administered orally in 91 advanced cancer patients whose pain intensity varied from moderate to severe, have been compared. The number of hours of sleep and hours standing after administration of both the drugs were also assessed and in 16 patients life activity was taken into consideration. The analysis of data showed: 1) a better pain control with buprenorphine, than with pentazocine, with a statistically significant difference of P <0.001; 2) an increase in the number of hours of sleep with buprenorphine, in comparison with pentazocine, with P <0.001; 3) an increase in the number of hours standing with buprenorphine, in comparison with pentazocine; 4) as for side effects, many more patients had to stop treatment with pentazocine than with buprenorphine.

Translated title of the contributionBuprenorphine in the treatment of cancer pain: Comparison with pentazocine
Original languageItalian
Pages (from-to)1177-1181
Number of pages5
JournalMinerva Medica
Volume78
Issue number15
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Buprenorphine in the treatment of cancer pain: Comparison with pentazocine'. Together they form a unique fingerprint.

Cite this